100
Participants
Start Date
June 30, 2010
Primary Completion Date
May 31, 2013
Study Completion Date
June 30, 2015
generic FDC of TDF/3TC/EFV
Patients who were on individual TDF 3TC and EFV regimen before baseline will undergo TDM at baseline. Therapeutic drug monitoring (TDM) of generic FDC of TDF/3TC/EFV will be done after 4 weeks, to ensure steady state. At baseline and week 4 safety data will be obtained. In order to assess the efficacy and the long term safety of this drug, at week 12, 24 and 48 viral load, CD4 and safety parameters will be obtained.
HIV-NAT, Bangkok
Collaborators (1)
Mylan Laboratories
INDUSTRY
The HIV Netherlands Australia Thailand Research Collaboration
OTHER